Institutional investors purchased a net $15.9 million shares of TEVA during the quarter ended September 2014, and now own 53.84% of the total float, a percentage that is typical for companies in the Pharmaceuticals: Generic industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
NORDEA INVESTMENT MANAGEMENT AB ... Bought 1.4 Million shares of Teva Pharmaceutical